Search

Now showing items 1-4 of 4

ReAl-life Multicenter Survey Evaluating Stroke prevention strategies in non-valvular atrial fibrillation (RAMSES study)

Başaran, Özcan; Beton, Osman; Doğan, Volkan; Tekinalp, Mehmet; Aykan, Ahmet Çağrı; Kalaycıoğlu, Ezgi; Biteker, Murat (Turkish Soc Cardiology, 2016)

Objective: Data regarding stroke prevention strategies in non-valvular atrial fibrillation (NVAF) are limited to vitamin K antagonists (VKAs). This study aimed to evaluate real-life stroke prevention strategies for NVAF ...

Impact of valvular heart disease on oral anticoagulant therapy in non-valvular atrial fibrillation: results from the RAMSES study

Başaran, Özcan; Doğan, Volkan; Beton, Osman; Tekinalp, Mehmet; Aykan, Ahmet Çagrı; Kalaycıoğlu, Ezgi; Biteker, Murat (Springer, 2017)

The definition of non-valvular atrial fibrillation (NVAF) is controversial. We aimed to assess the impact of valvular heart disease on stroke prevention strategies in NVAF patients. The RAMSES study was a multicenter and ...

Guideline-adherent therapy for stroke prevention in atrial fibrillation in different health care settings: Results from RAMSES study

Başaran, Özcan; Doğan, Volkan; Biteker, Murat; Karadeniz, Fatma Özpamuk; Tekkesin, Ahmet İlker; Çakıllı, Yasin; Kırma, Cevat (Elsevier Science Bv, 2017)

Objective: No studies have been conducted in Turkey to compare the quality of stroke prevention therapies provided in different healthcare settings in patients with atrial fibrillation (AF). Therefore, we aimed to evaluate ...

Real-World Clinical Characteristics and Treatment Patterns of Individuals Aged 80 and Older with Nonvalvular Atrial Fibrillation: Results from the ReAl-life Multicenter Survey Evaluating Stroke Study

Biteker, Murat; Başaran, Özcan; Doğan, Volkan; Altun, İbrahim; Karadeniz, Fatma Özpamuk; Tekkesin, Ahmet İlker; Bozyel, Serdar (Wiley, 2017)

ObjectivesTo compare the clinical characteristics of and use of oral anticoagulant (OAC) therapy in individuals aged 80 and older with atrial fibrillation (AF) with those of individuals younger than 80 with AF in clinical ...